Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v15-FR
Language English French
Date Updated 2023-02-11 2023-02-10
Drug Identification Number 00710814 00710814
Brand name EPINEPHRINE INJECTION USP EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP EPINEPHRINE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRACARDIAC INTRAVENOUS INTRACARDIAC INTRAVENOUS INTRACARDIAC INTRAVENOUS INTRACARDIAC
Packaging size 10 x 10mL LifeShield syringes 10 x 10mL LifeShield syringes
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-28 2022-01-28
Estimated end date
Actual end date 2023-02-10 2023-02-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments